The store will not work correctly when cookies are disabled.
1-(2-fluoroethyl)-4,4-dimethyl-1,4-dihydropyrrolo[2',3':4,5]pyrano[2,3-c]pyridine-2-carboxamide
ID: ALA4779550
PubChem CID: 126638433
Max Phase: Preclinical
Molecular Formula: C15H16FN3O2
Molecular Weight: 289.31
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(C)Oc2cnccc2-c2c1cc(C(N)=O)n2CCF
Standard InChI: InChI=1S/C15H16FN3O2/c1-15(2)10-7-11(14(17)20)19(6-4-16)13(10)9-3-5-18-8-12(9)21-15/h3,5,7-8H,4,6H2,1-2H3,(H2,17,20)
Standard InChI Key: BIBOVMGNFAPEJA-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
11.9855 -8.7786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6918 -9.1895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9813 -9.5958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6004 -7.4166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1610 -7.9696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1599 -8.7892 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8679 -9.1981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8661 -7.5608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5748 -7.9660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5736 -8.7867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2821 -7.5545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9911 -7.9639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2667 -6.6681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4525 -6.7537 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6754 -5.9605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4926 -5.9605 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2668 -5.2527 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.2819 -9.1943 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9058 -6.1463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1584 -5.3692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6117 -4.7618 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
5 6 2 0
6 7 1 0
7 10 2 0
9 8 2 0
8 5 1 0
9 10 1 0
9 11 1 0
1 12 1 0
11 12 2 0
12 4 1 0
4 13 2 0
13 14 1 0
14 11 1 0
13 15 1 0
15 16 1 0
15 17 2 0
10 18 1 0
18 1 1 0
14 19 1 0
19 20 1 0
20 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 289.31 | Molecular Weight (Monoisotopic): 289.1227 | AlogP: 2.25 | #Rotatable Bonds: 3 |
Polar Surface Area: 70.14 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.91 | CX LogP: 0.89 | CX LogD: 0.89 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.94 | Np Likeness Score: -0.35 |
References
1. (2018) Condensed tricyclic compounds as protein kinase inhibitors, |